Quick Answer
Intellia Therapeutics, Inc. reported Shares Outstanding of 116.32 million shares for fiscal year 2025.
Intellia Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 116.32M | +14.0% |
| 2024 | 102.03M | +9.7% |
| 2023 | 93.00M | +6.8% |
| 2022 | 87.10M | +16.9% |
| 2021 | 74.49M | +12.5% |
| 2020 | 66.23M | +31.9% |
| 2019 | 50.20M | +11.0% |
| 2018 | 45.22M | +6.7% |
| 2017 | 42.38M | +17.7% |
| 2016 | 36.02M | +1307.7% |
| 2015 | 2.56M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 115.79M | +13.7% | +9.9% |
| June 30, 2025 | 105.33M | +7.2% | +1.7% |
| March 31, 2025 | 103.54M | +7.5% | +1.5% |
| December 31, 2024 | 102.03M | +9.7% | +0.2% |
| September 30, 2024 | 101.80M | +14.3% | +3.6% |
| June 30, 2024 | 98.29M | +11.3% | +2.0% |
| March 31, 2024 | 96.33M | +9.4% | +3.6% |
| December 31, 2023 | 93.00M | +6.8% | +4.4% |
- Intellia Therapeutics, Inc. showed an increase of +14.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2015–2025 period, Intellia Therapeutics, Inc.’s shares outstanding has grown by 4445.8% (from 2.56 million shares to 116.32 million shares).
- The most recent figure is from Intellia Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: